Equities analysts expect Ceridian HCM Holding Inc (NYSE:CDAY) to post earnings per share (EPS) of $0.09 for the current quarter, according to Zacks. Six analysts have provided estimates for Ceridian HCM’s earnings, with estimates ranging from ($0.07) to $0.15. Ceridian HCM reported earnings per share of ($0.11) in the same quarter last year, which suggests a positive year over year growth rate of 181.8%. The company is scheduled to issue its next earnings report on Tuesday, May 28th.
According to Zacks, analysts expect that Ceridian HCM will report full year earnings of $0.44 per share for the current year, with EPS estimates ranging from $0.20 to $0.55. For the next fiscal year, analysts anticipate that the firm will post earnings of $0.72 per share, with EPS estimates ranging from $0.60 to $0.89. Zacks Investment Research’s earnings per share calculations are a mean average based on a survey of sell-side research analysts that that provide coverage for Ceridian HCM.
Ceridian HCM (NYSE:CDAY) last announced its quarterly earnings data on Wednesday, February 6th. The company reported $0.07 earnings per share (EPS) for the quarter, missing the Zacks’ consensus estimate of $0.08 by ($0.01). Ceridian HCM had a negative net margin of 6.82% and a positive return on equity of 0.04%. The company had revenue of $200.30 million for the quarter, compared to the consensus estimate of $196.56 million. The firm’s quarterly revenue was up 9.8% compared to the same quarter last year.
CDAY has been the topic of several recent research reports. Mitsubishi UFJ Financial Group upped their target price on shares of Ceridian HCM from $40.00 to $56.00 and gave the company an “overweight” rating in a research report on Tuesday, April 9th. Goldman Sachs Group began coverage on shares of Ceridian HCM in a research note on Friday, February 1st. They issued a “neutral” rating and a $37.00 price target on the stock. Piper Jaffray Companies reissued an “overweight” rating and issued a $50.00 price target on shares of Ceridian HCM in a research note on Thursday, February 7th. Needham & Company LLC began coverage on shares of Ceridian HCM in a research note on Thursday, January 3rd. They issued a “buy” rating and a $40.00 price target on the stock. Finally, Zacks Investment Research raised shares of Ceridian HCM from a “hold” rating to a “buy” rating and set a $52.00 price target on the stock in a research note on Thursday, February 7th. Eight research analysts have rated the stock with a hold rating, seven have issued a buy rating and one has issued a strong buy rating to the company. The company presently has a consensus rating of “Buy” and a consensus price target of $43.40.
In related news, CFO Arthur Gitajn sold 86,500 shares of Ceridian HCM stock in a transaction that occurred on Wednesday, February 20th. The shares were sold at an average price of $47.01, for a total value of $4,066,365.00. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, Director Thomas H. Lee Advisors, Llc sold 13,000,000 shares of Ceridian HCM stock in a transaction that occurred on Friday, March 22nd. The shares were sold at an average price of $48.99, for a total transaction of $636,870,000.00. The disclosure for this sale can be found here. Insiders sold 14,364,892 shares of company stock valued at $703,169,802 in the last 90 days. Company insiders own 26.90% of the company’s stock.
A number of hedge funds and other institutional investors have recently bought and sold shares of the business. Deutsche Bank AG grew its holdings in Ceridian HCM by 23.8% during the 4th quarter. Deutsche Bank AG now owns 1,425 shares of the company’s stock worth $48,000 after acquiring an additional 274 shares in the last quarter. Geode Capital Management LLC grew its position in Ceridian HCM by 63.4% in the fourth quarter. Geode Capital Management LLC now owns 329,421 shares of the company’s stock valued at $11,361,000 after acquiring an additional 127,800 shares during the period. Norges Bank bought a new stake in Ceridian HCM in the fourth quarter valued at $3,766,000. Dimensional Fund Advisors LP bought a new stake in Ceridian HCM in the fourth quarter valued at $223,000. Finally, UBS Oconnor LLC bought a new stake in Ceridian HCM in the fourth quarter valued at $1,400,000. Institutional investors own 80.11% of the company’s stock.
Shares of NYSE:CDAY traded up $0.28 on Wednesday, reaching $51.76. 1,702 shares of the company traded hands, compared to its average volume of 1,099,056. Ceridian HCM has a 52 week low of $28.65 and a 52 week high of $52.60. The stock has a market capitalization of $7.13 billion and a P/E ratio of -1,035.50. The company has a current ratio of 1.06, a quick ratio of 1.06 and a debt-to-equity ratio of 0.43.
About Ceridian HCM
Ceridian HCM Holding Inc operates as a human capital management (HCM) software company in the United States and internationally. The company offers Dayforce, a cloud HCM platform that provides human resources (HR), payroll, benefits, workforce management, and talent management functionality; and Powerpay, a cloud platform, which offers scalable and straightforward payroll and HR solutions.
Recommended Story: Liquidity
Get a free copy of the Zacks research report on Ceridian HCM (CDAY)
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Ceridian HCM Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ceridian HCM and related companies with MarketBeat.com's FREE daily email newsletter.